119-s2842

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. 2842 Introduced in Senate

    (IS) ]

<DOC>

119th CONGRESS
 1st Session
 S. 2842

 To amend the Public Health Service Act to provide for congenital 
 Cytomegalovirus screening of newborns.

_______________________________________________________________________

 IN THE SENATE OF THE UNITED STATES

 September 17 (legislative day, September 16), 2025

 Mr. Blumenthal (for himself, Mr. Marshall, and Mr. Kelly) introduced 
the following bill; which was read twice and referred to the Committee 
 on Health, Education, Labor, and Pensions

_______________________________________________________________________

 A BILL

 To amend the Public Health Service Act to provide for congenital 
 Cytomegalovirus screening of newborns.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as ``Stop CMV Act of 2025''.

SEC. 2. SCREENING OF CONGENITAL CYTOMEGALOVIRUS.

 Part A of title XI of the Public Health Service Act is amended by 
inserting after 

section 1116 (42 U.S.C. 300b-15) the following:

``

SEC. 1116A. SCREENING OF CONGENITAL CYTOMEGALOVIRUS.

 ``

    (a) In General.--Each hospital or other health care entity caring 
for infants who are 21 days or less of age (as designated by the 
Secretary) may administer, or cause to have administered, to every such 
infant in its care a test for congenital Cytomegalovirus in accordance 
with this section.
 ``

    (b) Process.--
 ``

    (1) In general.--In carrying out this section, the chief 
 executive officer for health in each State may prescribe 
 standards and procedures for the administration of testing 
 under subsection

    (a) , including recording the results of such 
 tests, tracking activities, conducting follow-up reviews, and 
 carrying out educational activities.
 ``

    (2) Dissemination of information.--In carrying out this 
 section, the chief executive officer for health in each State 
 may prescribe standards and procedures setting forth the manner 
 in which testing information is disseminated to a parent or 
 guardian of the infant to be tested.
 ``

    (3) Failure to prescribe.--If a State has not prescribed 
 standards and procedures that are approved as provided for in 
 paragraph

    (4) by the date that is 2 years after the date of 
 enactment of the Stop CMV Act of 2025, the Discretionary 
 Advisory Committee on Heritable Disorders in Newborns and 
 Children established under 

section 1111 (referred to in this 
 section as the `Advisory Committee') shall prescribe 
 appropriate standards and procedures which may be implemented 
 by such State.
 ``

    (4) Review and approval.--The standards and procedures 
 prescribed under this subsection shall be subject to review and 
 approval by the Advisory Committee. In reviewing or prescribing 
 standards and procedures as required under this subsection, the 
 Advisory Committee shall consider standards and procedures 
 adopted in other States with respect to the screening of 
 congenital Cytomegalovirus, the standards and procedures 
 adopted in such State with respect to the screening of infants 
 for other heritable diseases, and any scientific evidence the 
 Advisory Committee considers relevant to provide for the 
 screening of infants for congenital Cytomegalovirus.
 ``
            (c) Grants.--
 ``

    (1) Health resources and services administration.--
 ``
        (A) In general.--The Secretary, acting through 
 the Administrator of the Health Resources and Services 
 Administration, shall award grants to States that 
 prescribe standards and procedures in accordance with 
 paragraphs

    (1) and

    (2) , to be distributed by the States 
 to entities described in subsection

    (a) to administer 
 tests in accordance with that subsection.
 ``
        (B) Authorization of appropriations.--There is 
 authorized to be appropriated to carry out subparagraph
        (A) such sums as may be necessary for each of fiscal 
 years 2026 and 2027.
 ``

    (2) Centers for disease control and prevention.--
 ``
        (A) In general.--The Secretary, acting through 
 the Director of the Centers for Disease Control and 
 Prevention, shall award grants to, or enter into 
 cooperative agreements with, States to provide 
 technical assistance to State agencies or designated 
 entities of States--
 ``
            (i) to develop, maintain, and improve 
 data collection systems relating to congenital 
 Cytomegalovirus; and
 ``
            (ii) to assist in the education and 
 training of health care providers, patients, 
 and the general public regarding the risk 
 reduction or prevention, symptoms, diagnosis, 
 and treatment of congenital Cytomegalovirus, 
 including, as necessary, through the 
 publication of scientific, evidence-based 
 educational materials on internet webpages 
 maintained by State agencies or designated 
 entities of States.
 ``
        (B) Authorization of appropriations.--There is 
 authorized to be appropriated to carry out subparagraph
        (A) such sums as may be necessary for each of fiscal 
 years 2026 and 2027.
 ``

    (3) National institutes of health.--
 ``
        (A) In general.--The Director of the National 
 Institutes of Health shall--
 ``
            (i) for the purposes of this section, 
 establish a program, or expand existing 
 programs, of research and development on the 
 efficacy of new screening techniques and 
 technology relating to congenital 
 Cytomegalovirus, including clinical studies of 
 screening methods, studies on efficacy of 
 intervention, and related research; and
 ``
            (ii) establish a program, or expand 
 existing programs, of research and development 
 into congenital Cytomegalovirus diagnostics, 
 prevention, treatments including public health 
 awareness campaigns, risk reduction, and 
 vaccine development, and cures or treatments 
 (during pregnancy and after birth).
 ``
        (B) Funding.--The Director of the National 
 Institutes of Health shall carry out subparagraph
        (A) using amounts available to the Director and not 
 otherwise obligated.''.

SEC. 3. ADVISORY COMMITTEE ON HERITABLE DISORDERS IN NEWBORNS AND 
 CHILDREN.

 

Section 1111

    (b) of the Public Health Service Act (42 U.S.C. 300b-
10

    (b) ) is amended--

    (1) in paragraph

    (7) by striking ``and'' after the 
 semicolon;

    (2) by redesignating paragraph

    (8) as paragraph

    (9) ; and

    (3) by inserting after paragraph

    (7) the following:
 ``

    (8) carry out activities under 

section 1116A; and''.
 <all>